Supply Chain | April 17, 2026
DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
Call it a major breakthrough for diagnostic imaging
At the center of the announcement are two late-breaking studies that could reshape treatment approaches for patients with high cholesterol and a complex form of heart failure
There are limited treatment options available for patients living with non-diabetic CKD, and the unmet need is high for new treatments to delay kidney disease progression and reduce cardiovascular risk
The initiative will focus on creating healthier early-life environments, promoting physical activity, identifying risks early, and strengthening preparedness within primary health care systems
Germany will be the first launch market
Under the deal, Hims & Hers will offer patients access to FDA-approved versions of Ozempic and Wegovy at the same self-pay prices available through other telehealth platforms
The company said the move applies to all doses and reflects its commitment to making its medicines more affordable for patients
Subscribe To Our Newsletter & Stay Updated
